Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.118 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
GJ.1.2.7NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.36.35NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
CH.1.1.18NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.610NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
BQ.1.21NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
BN.1.3.11NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
AY.92 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
BF.11.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
AY.21 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.531NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.1.396NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
AY.17 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.1.355NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19343Hong Kong
B.1.39NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19353.7US
B.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
B.1.1.158NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
P.1 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
AY.125 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
B.1.36.31SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-19370Singapore
B.1.1.135NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19375South Korea
FK.1.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FP.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.34.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.8.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GY.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBF.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.4.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DS.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.87ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.6.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.47.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBF.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FW.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.29ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBNECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CA.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CA.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.3.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EP.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.4.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.29ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.74ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used